Exploring the Link Between Antipsychotic Drugs and Metabolic Disease in Patients: Uncovering the Mechanisms

Dr. Houseknecht’s career, which has spanned academic and corporate research
environments, has focused on her unwavering passion around the discovery and development of novel therapeutics, including pharmaceutical, biologic and nutritional therapies for the treatment of metabolic disorders such as diabetes and obesity. She received her BS from Virginia Tech, an MS from the University of Georgia and her PhD from Cornell University.

Prior to joining UNE, she served as Vice President of Global Research and Development at ASDI, Inc., a multinational company providing products and services for clients in the pharmaceutical, biotech, academic and NGO research sectors. She has previously led drug discovery research teams at Pfizer, Inc., most recently serving as Associate Research Fellow, Diabetes Drug Discovery, Division of Cardiovascular, Metabolic and Endocrine Diseases.

Dr. Houseknecht is the author of over 40 scientific publications and patents and has also served as assistant professor of Endocrinology and Metabolism, at Purdue University and Adjunct Assistant Professor of Medicine, Indiana University Medical School. Throughout her career, she has been an advocate for women in science and has served as a scientific mentor both in academia and the pharmaceutical industry. She is the recipient of the 2005 Power of Women Award for her work supporting educational and leadership opportunities for women and girls.